Clinical Trial Update: Artificial Intelligence Enhanced ECG to Detect Cardiac Amyloidosis [NA]

View source ↗

Summary

A completed clinical trial evaluating an artificial intelligence–enhanced ECG method for detecting cardiac amyloidosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Amyloidosis

Snippet

Sponsor: Mayo Clinic | Conditions: Cardiac Amyloidosis | NA | Status: COMPLETED